Matthijs A Velders1, Stefan K James2, Berglind Libungan3, Giovanna Sarno4, Ole Fröbert5, Jörg Carlsson6, Martin J Schalij7, Per Albertsson3, Bo Lagerqvist4. 1. Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden; Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands. 2. Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden. Electronic address: Stefan.james@ucr.uu.se. 3. Department of Cardiology, Sahlgrenska University Hospital, Göteborg, Sweden. 4. Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden. 5. Department of Cardiology, Örebro University Hospital, Örebro, Sweden. 6. Department of Cardiology, Kalmar Hospital, Kalmar, Sweden. 7. Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.
Abstract
BACKGROUND: Elderly patients constitute a growing part of the population presenting with ST-elevation myocardial infarction (STEMI). The use of primary percutaneous coronary intervention (PCI) in this high-risk population remains poorly investigated. METHODS: Using the Swedish Coronary Angiography and Angioplasty Registry (SCAAR), we identified consecutive patients with STEMI 80 years or older undergoing primary PCI during a 10-year period. Temporal trends in care and 1-year prognosis were investigated, and long-term outcome was compared with a reference group of patients with STEMI aged 70 to 79 years. Relative survival was calculated by dividing the observed survival rate with the expected survival rate of the general population. Adjusted end points were calculated using Cox regression. RESULTS: In total, 4,876 elderly patients with STEMI were included. During the study period, average age and presence of comorbidity increased, as well as the use of antithrombotic therapy. Procedural success remained constant. One-year mortality was exclusively reduced between the most recent vs the earliest cohort, whereas the risk of reinfarction, heart failure, stroke, and bleeding remained similar. The risk of death was higher for elderly patients early after PCI, after which the prognosis was slightly better compared with the general population. Long-term risk of adverse events increased markedly with age. CONCLUSIONS: The prognosis of patients older than 80 years treated with primary PCI for STEMI was relatively unchanged during the 10-year inclusion period, despite changes in patient characteristics and treatment. Advanced age increased the risk of adverse events, but survivors of the early phase after PCI had a slightly improved prognosis compared with the general population.
BACKGROUND: Elderly patients constitute a growing part of the population presenting with ST-elevation myocardial infarction (STEMI). The use of primary percutaneous coronary intervention (PCI) in this high-risk population remains poorly investigated. METHODS: Using the Swedish Coronary Angiography and Angioplasty Registry (SCAAR), we identified consecutive patients with STEMI 80 years or older undergoing primary PCI during a 10-year period. Temporal trends in care and 1-year prognosis were investigated, and long-term outcome was compared with a reference group of patients with STEMI aged 70 to 79 years. Relative survival was calculated by dividing the observed survival rate with the expected survival rate of the general population. Adjusted end points were calculated using Cox regression. RESULTS: In total, 4,876 elderly patients with STEMI were included. During the study period, average age and presence of comorbidity increased, as well as the use of antithrombotic therapy. Procedural success remained constant. One-year mortality was exclusively reduced between the most recent vs the earliest cohort, whereas the risk of reinfarction, heart failure, stroke, and bleeding remained similar. The risk of death was higher for elderly patients early after PCI, after which the prognosis was slightly better compared with the general population. Long-term risk of adverse events increased markedly with age. CONCLUSIONS: The prognosis of patients older than 80 years treated with primary PCI for STEMI was relatively unchanged during the 10-year inclusion period, despite changes in patient characteristics and treatment. Advanced age increased the risk of adverse events, but survivors of the early phase after PCI had a slightly improved prognosis compared with the general population.
Authors: Andriy Yabluchanskiy; Yonggang Ma; Kristine Y DeLeon-Pennell; Raffaele Altara; Ganesh V Halade; Andrew P Voorhees; Nguyen T Nguyen; Yu-Fang Jin; Michael D Winniford; Michael E Hall; Hai-Chao Han; Merry L Lindsey Journal: J Gerontol A Biol Sci Med Sci Date: 2015-04-15 Impact factor: 6.053
Authors: Mayra Tisminetzky; Nathaniel Erskine; Han-Yang Chen; Joel Gore; Jerry Gurwitz; Jorge Yarzebski; Samuel Joffe; Peter Shaw; Robert Goldberg Journal: J Am Geriatr Soc Date: 2015-05-04 Impact factor: 5.562
Authors: Abdulla A Damluji; Karen Bandeen-Roche; Carol Berkower; Cynthia M Boyd; Mohammed S Al-Damluji; Mauricio G Cohen; Daniel E Forman; Rahul Chaudhary; Gary Gerstenblith; Jeremy D Walston; Jon R Resar; Mauro Moscucci Journal: J Am Coll Cardiol Date: 2019-04-23 Impact factor: 24.094
Authors: Bimmer E P M Claessen; Wouter J Kikkert; Loes P Hoebers; Hassina Bahadurzada; Marije M Vis; Jan Baan; Karel T Koch; Robbert J de Winter; Jan G P Tijssen; Jan J Piek; José P S Henriques Journal: Neth Heart J Date: 2015-09 Impact factor: 2.380
Authors: Per Hammar; Anna M Nordenskjöld; Bertil Lindahl; Olov Duvernoy; Håkan Ahlström; Lars Johansson; Nermin Hadziosmanovic; Tomas Bjerner Journal: J Cardiovasc Magn Reson Date: 2015-11-19 Impact factor: 5.364